Order Article Reprints

Birindelli G, Drobnjakovic M, Morath V, Steiger K, D’Alessandria C, Gourni E, Afshar-Oromieh A, Weber W, Rominger A, Eiber M, et al. Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers. 2021; 13(14):3429. https://doi.org/10.3390/cancers13143429

Birindelli, Gabriele, Milos Drobnjakovic, Volker Morath, Katja Steiger, Calogero D’Alessandria, Eleni Gourni, Ali Afshar-Oromieh, Wolfgang Weber, Axel Rominger, Matthias Eiber, and et al. 2021. "Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer" Cancers 13, no. 14: 3429. https://doi.org/10.3390/cancers13143429

Birindelli, G., Drobnjakovic, M., Morath, V., Steiger, K., D’Alessandria, C., Gourni, E., Afshar-Oromieh, A., Weber, W., Rominger, A., Eiber, M., & Shi, K. (2021). Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers, 13(14), 3429. https://doi.org/10.3390/cancers13143429